Integrating Screening, Brief Interventions, & Treatment for Stimulant Use Disorder during Buprenorphine Treatment for Opioid Use Disorder in Primary Care-2 Screening, Diagnosis, and Brief Intervention

2 Screening, Diagnosis, and Brief Intervention

Video Transcription

Video Summary

<p style="margin: 0in; line-height: 115%; font-size: 11pt; font-family: Arial, sans-serif;"><strong>Screening, Diagnosis, and Brief Intervention</strong></p>
<p style="margin: 0in; line-height: 115%; font-size: 11pt; font-family: Arial, sans-serif;">Author: Derek Blevins, MD, Assistant Professor of Psychiatry, Columbia University</p>
<p style="margin: 0in; line-height: 115%; font-size: 11pt; font-family: Arial, sans-serif;">This webinar will explore the usage of screening tools of varying lengths to evaluate stimulant use, urine drug testing advantages and limitations for patients on MOUD, comprehensive assessment guides, brief intervention strategies and referral conditions, and the role of harm reduction in all levels of care for stimulant use disorder.</p>

Keywords

Screening

Diagnosis

Brief Intervention

Stimulant Use

Urine Drug Testing

Comprehensive Assessment

Harm Reduction